Clinical Trials Directory

Trials / Completed

CompletedNCT01762891

CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen

CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen. A Prospective Double-blind, Placebo Controlled Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Hospital Universitario Pedro Ernesto · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Coumadin drug-drug interactions (DDI) are frequent. Patients in permanent use of coumadin are advised to avoid traditional nonsteroidal antiinflammatory drugs to avoid risk of bleeding. New selctive cyclooxygesase 2 inhibitors arisen as potential option for treating pain and inflamation in these patients once interactions with coumadin are supposed to be lower. The CI(R)CA study was made to evaluate in a prospective fashion the occurrence of DDI with new cyclooxygenase antiinflammatory drugs and coumadin when compared to acetaminophen and placebo.

Detailed description

The CI(R)CA study included patient diagnosed with antiphospholipid syndrome in permanent use of coumadin. Eligible patients were invited to use in a prospective cross-over mode two weeks of celecoxib, rofecoxib, acetaminophen and placebo with two weeks of wash out between drugs. Their international normalized ratio (INR) were measured before and during the use of each study drug. The interaction with coumadin was evaluated according to increases or decreases on the INR after each medication.

Conditions

Interventions

TypeNameDescription
DRUGCelecoxibcelecoxib 200mg/day by oral rout during 15 days followed by the administration of rofecoxib 25mg/day, acetaminophen 3g/day and placebo during 15 days each drug.
DRUGAcetaminophenAcetaminophen 3g/ was given during 15 days by oral rout following one of the other interventions or as the final intervention.
DRUGRofecoxibRofecoxib 25mg/day was given by oral rout during 15 days following one or more interventions or as the final intervention.
DRUGplaceboPlacebo pills were given during 15 days by oral rout as one of the four interventions.

Timeline

Start date
2003-03-01
Primary completion
2006-07-01
Completion
2009-09-01
First posted
2013-01-08
Last updated
2013-01-08

Source: ClinicalTrials.gov record NCT01762891. Inclusion in this directory is not an endorsement.